Skip to main content
Erschienen in: Clinical Rheumatology 10/2008

01.10.2008 | Original Article

Accuracy of recall of the items included in disease activity forms of Behçet’s disease: comparison of retrospective questionnaires with a daily telephone interview

verfasst von: Ismail Simsek, Coskun Meric, Hakan Erdem, Salih Pay, Selim Kilic, Ayhan Dinc

Erschienen in: Clinical Rheumatology | Ausgabe 10/2008

Einloggen, um Zugang zu erhalten

Abstract

The assessment of disease activity in Behçet’s disease (BD), either by BD Current Activity Form (BDCAF) or Iranian BD Dynamic Measure (IBDDAM), depends largely on the history of the clinical features. Accuracy of recall of a retrospective questionnaire might influence its reliability to some extent. The aim of this study was to investigate whether patients with BD can recall the items included in both of the disease activity forms accurately. Twenty patients with BD completed a retrospective questionnaire that included BDCAF and IBDDAM, twice, 1 month apart. We made some modifications in the IBDDAM, while the BDCAF (revised 8.5.2002, GL) was applied in its original structure. In contrast to the original application of IBDDAM, in which the history obtained depends on the variable time period, all items of IBDDAM in the present study asked subjects to report their symptoms over the preceding 4 weeks. Furthermore, those IBDDAM items for which the operational definitions are not clearly provided by the developers, as well as the items that depend on the objective examination rather than the history, were not included. Concurrent daily data were collected for 2 months via telephone interview. The level of agreement between the retrospective responses and those extracted from daily recordings were quantified for each item using intraclass correlation coefficient (ICC). The agreement between the recalled and daily reports was good (ICCs > 0.60) for the majority of items (oral and genital ulceration, skin lesions, arthralgia, arthritis, and eye involvement) included in BDCAF. Exceptions were gastrointestinal symptoms (ICCs < 0.40) and headache (ICCs 0.40–0.50). With regard to the IBDDAM, all of the items examined had good agreement (ICCs > 0.60), except for headache, for which the agreement was moderate (ICCs 0.40–0.50) for the first and poor (ICCs < 0.40) for the second month. For most of the BD-related features questioned in the disease activity forms, patients provided reasonably accurate reports in comparison to information obtained from daily records. However, it should be kept in mind that the limitations of the study design need to be considered while interpreting the results of the present study. Notably, unlike its original application in which the assessment depends on the variable time period, IBDDAM used in the present study assessed the symptoms present during the month prior to the date of assessment. Therefore, our findings regarding IBDDAM cannot be applied to its original use. Furthermore, lack of patients in some of the symptom groups, as well as possible manipulation of recall with daily questioning, might have influenced our results to some extent.
Literatur
1.
Zurück zum Zitat Yazici H, Fresko I, Tunc R, Melikoglu M (2002) Vasculitis. In: Ball GV, Bridges SL (eds) Behçet’s syndrome: pathogenesis, clinical manifestations and treatment. Oxford University Press, New York, pp 406–432 Yazici H, Fresko I, Tunc R, Melikoglu M (2002) Vasculitis. In: Ball GV, Bridges SL (eds) Behçet’s syndrome: pathogenesis, clinical manifestations and treatment. Oxford University Press, New York, pp 406–432
2.
Zurück zum Zitat International Study Group for Behçet’s Disease (1992) Evaluation of diagnostic (classification) criteria in Behçet’s Disease—towards internationally agreed criteria. Br J Rheumatol 31:299–308CrossRef International Study Group for Behçet’s Disease (1992) Evaluation of diagnostic (classification) criteria in Behçet’s Disease—towards internationally agreed criteria. Br J Rheumatol 31:299–308CrossRef
3.
Zurück zum Zitat Davatchi F, Akbaran M, Shahram F et al (1991) Iran Behçet’s Disease Dynamic Activity Measure. Abstracts of the XIIth European Congress of Rheumatology. Hung Rheumatol Suppl 32:FP10–FP100 Davatchi F, Akbaran M, Shahram F et al (1991) Iran Behçet’s Disease Dynamic Activity Measure. Abstracts of the XIIth European Congress of Rheumatology. Hung Rheumatol Suppl 32:FP10–FP100
4.
Zurück zum Zitat Lippman A, Mackenzie SG (1985) What is “recall bias” and does it exist? Prog Clin Biol Res 163C:205–209PubMed Lippman A, Mackenzie SG (1985) What is “recall bias” and does it exist? Prog Clin Biol Res 163C:205–209PubMed
5.
6.
Zurück zum Zitat Bhakta B, Hamuryudan V, Brennan P, Chamberlain MA, Barnes C, Silman AJ (1993) Assessment of disease activity in Behçet’s disease. In: Wechsler B, Godeau P (eds) Excerpta Medica Int Congress Series 1037, 611. Elsevier, Amsterdam, pp 235–240 Bhakta B, Hamuryudan V, Brennan P, Chamberlain MA, Barnes C, Silman AJ (1993) Assessment of disease activity in Behçet’s disease. In: Wechsler B, Godeau P (eds) Excerpta Medica Int Congress Series 1037, 611. Elsevier, Amsterdam, pp 235–240
7.
Zurück zum Zitat Hamuryudan V, Fresko İ, Direskeneli H et al (1999) Evaluation of the Turkish translation of a disease activity form for Behçet’s syndrome. Rheumatology 38:734–736PubMedCrossRef Hamuryudan V, Fresko İ, Direskeneli H et al (1999) Evaluation of the Turkish translation of a disease activity form for Behçet’s syndrome. Rheumatology 38:734–736PubMedCrossRef
8.
Zurück zum Zitat Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ (1999) Behçet’s disease: evaluation of new instrument to measure clinical activity. Rheumatology 38:728–733PubMedCrossRef Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ (1999) Behçet’s disease: evaluation of new instrument to measure clinical activity. Rheumatology 38:728–733PubMedCrossRef
9.
Zurück zum Zitat Lawton G, Bhakta BB, Chamberlain MA, Tennant A (2004) The Behcet’s disease activity index. Rheumatology (Oxford) 43(1):73–78, JanCrossRef Lawton G, Bhakta BB, Chamberlain MA, Tennant A (2004) The Behcet’s disease activity index. Rheumatology (Oxford) 43(1):73–78, JanCrossRef
10.
Zurück zum Zitat Giovannucci E, Colditz G, Stampfer MJ et al (1991) The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol 133(8):810–817, Apr 15PubMed Giovannucci E, Colditz G, Stampfer MJ et al (1991) The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol 133(8):810–817, Apr 15PubMed
11.
Zurück zum Zitat Pietinen P, Hartman AM, Haapa E et al (1988) Reproducibility and validity of dietary assessment instruments. I.A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 128(3):655–666, SepPubMed Pietinen P, Hartman AM, Haapa E et al (1988) Reproducibility and validity of dietary assessment instruments. I.A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 128(3):655–666, SepPubMed
Metadaten
Titel
Accuracy of recall of the items included in disease activity forms of Behçet’s disease: comparison of retrospective questionnaires with a daily telephone interview
verfasst von
Ismail Simsek
Coskun Meric
Hakan Erdem
Salih Pay
Selim Kilic
Ayhan Dinc
Publikationsdatum
01.10.2008
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 10/2008
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-0899-8

Weitere Artikel der Ausgabe 10/2008

Clinical Rheumatology 10/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.